Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jill Hunter.

Newcastle AuthorsTitleYearFull text
Dr Evan Mulligan
Dr Susan Tudhope
Dr Jill Hunter
Sarah Elliott
Dr Jonathan Wallis
et al.
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling2023
Dr Suzanne Madgwick
Dr Saimir Luli
Helene Sellier
Dr Jacqueline Butterworth
Dr Jack Leslie
et al.
Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential2022
Dr Jill Hunter
Dr Elaine Willmore
Professor Julie Irving
Dr Stephany Veuger
Correction to: NF-kappa B mediates radio-sensitization by the PARP-1 inhibitor, AG-014699 (Oncogene, (2012), 31, 2, (251-264), 10.1038/onc.2011.229)2022
Dr Jack Leslie
Dr Jill Hunter
Amy Collins
Amelia Rushton
Lauren Russell
et al.
c-Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis2022
Dr Jill Hunter
Dr Jacqueline Butterworth
Helene Sellier
Dr Nicola Hannaway
Dr Saimir Luli
et al.
Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance2022
Dr Jill Hunter
Dr Nicola Hannaway
Scott Kerridge
Dr Saimir Luli
Dr Jacqueline Butterworth
et al.
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway2022
Dr Jill Hunter
Scott Kerridge
Dr Nicola Hannaway
Dr Saimir Luli
Dr Iglika Ivanova
et al.
Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells2022
Dr Jill Hunter
Lucy Salmon
Dr Caroline Wilson
Professor Neil Perkins
Dr Owen Davies
et al.
Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX122021
Dr Anna Moles Fernandez
Dr Jacqueline Butterworth
Dr Jill Hunter
Dr Jack Leslie
Helene Sellier
et al.
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kB dependent liver regeneration and cancer2016
Dr Jill Hunter
Jack Leslie
Professor Neil Perkins
c-Rel and its many roles in cancer: an old story with new twists2016
Dr Jill Hunter
Professor Neil Perkins
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma2016
Dr Jill Hunter
Dr Jacqueline Butterworth
Helene Sellier
Huw Thomas
Dr Christopher Bacon
et al.
The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma2016
Dr Anna Moles Fernandez
Dr Jacqueline Butterworth
Dr Jill Hunter
Professor Derek Mann
Professor Fiona Oakley
et al.
Mutation of Rela THR505 Enhances Liver Regeneration Following Partial Hepatectomy2015
Dr Elaine Willmore
Dr Aaron Ions Gardner
Dr Susan Tudhope
Belinda Murtani
Jessica Caffry
et al.
Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Patterson
et al.
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Anna Moles Fernandez
Dr Jacqueline Butterworth
Dr Jill Hunter
Dr Dina Tiniakos
Professor Derek Mann
et al.
Thr505 RelA phosphorylation controls liver proliferative response and supresses NF-kappa B tumor-promoting activities2015
Dr Adeline Ledoux
Dr Jill Hunter
Professor Neil Perkins
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy2014
Dr Jill Hunter
Dr Jacqueline Butterworth
Professor Neil Perkins
Professor Melissa Bateson
Dr Claire Richardson
et al.
Using body temperature, food and water consumption as biomarkers of disease progression in mice with Eμ-myc lymphoma2014
Dr Jill Hunter
Dr Elaine Willmore
Professor Julie Irving
Dr Stephany Veuger
Professor barbara Durkacz
et al.
NF-kappa B mediates radio-sensitization by the PARP-1 inhibitor, AG-0146992012
Dr Susan Tudhope
Dr Evan Mulligan
Dr Jill Hunter
Dr Helen Marr
Professor barbara Durkacz
et al.
P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells2012